ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,436.85
-0.43%
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs Yen
157.2625
0.00%
Brent Oil
81.295
0.00%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Immix Biopharma Inc (IMMX)

  7. Immix Biopharma Inc (IMMX) ニュース

IMMX

Immix Biopharma (IMMX)

Immix Biopharma Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:IMMX
日付受信時刻ニュースソース見出しコード企業名
2024/05/2205 : 05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106 : 27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106 : 27Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/1510 : 29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/1510 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/1005 : 27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMMXImmix Biopharma Inc
2024/02/0807 : 15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMMXImmix Biopharma Inc
2024/02/0623 : 09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMMXImmix Biopharma Inc
2024/02/0606 : 38Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMMXImmix Biopharma Inc
2024/02/0606 : 37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMMXImmix Biopharma Inc
2023/12/1308 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2023/11/2900 : 48InvestorsHub NewsWireImmix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient DosingNASDAQ:IMMXImmix Biopharma Inc
2023/11/1009 : 57Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IMMXImmix Biopharma Inc
2023/11/1009 : 54Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IMMXImmix Biopharma Inc
2023/09/2913 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IMMXImmix Biopharma Inc
2023/09/2605 : 15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IMMXImmix Biopharma Inc
2023/09/1908 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2023/09/1607 : 27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2023/09/1305 : 58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2023/08/3105 : 15Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:IMMXImmix Biopharma Inc
2023/08/2405 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2023/08/2405 : 26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2023/08/2305 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMMXImmix Biopharma Inc
2023/08/1505 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2023/08/1505 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2023/08/1505 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:IMMX

最近閲覧した銘柄

NASDAQ
SLAMW
Slam
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有